Event JSON
{
"id": "c643ad7b6aaac0cfde69a96d1f80175c075748892065faba170cad06ae03fea9",
"pubkey": "9824e73f2d2ada49816d43b8cd686b9f11b939cba1b1ec5ba9cc7c96e6265a80",
"created_at": 1739202923,
"kind": 1,
"tags": [
[
"r",
"https://abcnews.go.com/Health/wireStory/genedx-ceo-genetic-testing-newborn-118650633"
],
[
"subject",
"GeneDx CEO wants genetic testing for every newborn"
],
[
"published_at",
"1739202528"
],
[
"image",
"https://s.abcnews.com/images/US/abc_news_default_2000x2000_update_4x3t_384.jpg"
],
[
"p",
"9824e73f2d2ada49816d43b8cd686b9f11b939cba1b1ec5ba9cc7c96e6265a80",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://s.abcnews.com/images/US/abc_news_default_2000x2000_update_4x3t_384.jpg"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"GeneDx specializes in whole genome sequencing, looking at about 20,000 genes to identify potential diseases or conditions. The company's goal is to make genetic testing common at birth, which could help doctors begin treating diseases before symptoms appear. CEO Katherine Stueland believes that insurers would need to cover the roughly $2,000 tests routinely for this to become a reality."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqnqjww0ed9tdynqtdgwuv66rtnugmjwwt5xc7ckafe37fde3xt2qq4hznwr\nhttps://s.abcnews.com/images/US/abc_news_default_2000x2000_update_4x3t_384.jpg\nGeneDx is targeting a big market for its genetic testing: every newborn baby\nhttps://abcnews.go.com/Health/wireStory/genedx-ceo-genetic-testing-newborn-118650633",
"sig": "1064488f88953be9350bd980dceedc6db48193c192f0d39a020dfd1aa5862bd0b34a1c029b8e78cc4159bc731c8546741bc4a7468bf9cf9c2cd95c1ee290da1e"
}
